Shopping Cart
- Remove All
- Your shopping cart is currently empty
SIRT2-IN-15 (compound 1) acts as both a deacetylase and deglycosylase inhibitor for SIRT2, exhibiting IC50 values of 7 μM and 37 μM, respectively.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | SIRT2-IN-15 (compound 1) acts as both a deacetylase and deglycosylase inhibitor for SIRT2, exhibiting IC50 values of 7 μM and 37 μM, respectively. |
In vitro | SIRT2-IN-15 (compound 1) enhances acetylated α-tubulin levels in A549 lung cancer cells by inhibiting SIRT2. |
Molecular Weight | 499.12 |
Formula | C16H8BrIN2O2S |
Cas No. | 312275-43-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.